Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2013
03/28/2013US20130079422 Ophthalmic contact lens solutions containing forms of vitamin b
03/28/2013US20130079421 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
03/28/2013US20130079420 Novel thickening polymer for ionic oil phases free of monomers
03/28/2013US20130079404 Topical formulation
03/28/2013US20130079391 Lipase inhibiting composition
03/28/2013US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection
03/28/2013US20130079383 Lipid Compounds Targeting VLA-4
03/28/2013US20130079371 Bioadhesive Compositions of Local Anaesthetics
03/28/2013US20130079334 Compositions for Delivery of Insoluble Agents
03/28/2013US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
03/28/2013US20130079315 Ophthalmic Gel Compositions
03/28/2013US20130079311 Compositions and kits for compounding pharmaceuticals
03/28/2013US20130078312 Biodegradable Putty Compositions and Implant Devices, Methods, and Kits Relating to the Same
03/28/2013US20130078299 Transdermal Patches Having Ionized Beam Crosslinked Polymers and Improved Release Characteristics
03/28/2013US20130078289 Indigestible polymer: starch acetate -based film coatings for colon targeting
03/28/2013US20130078288 Method of Treating Cancer
03/28/2013US20130078283 Novel amphiphiles
03/28/2013US20130078282 Formulations decreasing particle exhalation
03/28/2013US20130078275 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
03/28/2013US20130078232 Compositions and methods useful for stabilizing protein-containing formulations
03/28/2013US20130078192 Use of neoflavonoids for flavor modification
03/28/2013US20130075703 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
03/28/2013CA2851492A1 Ophthalmic gel compositions
03/28/2013CA2850558A1 Beta-lactam compounds for treating diabetes
03/28/2013CA2849731A1 Acetaminophen conjugates, compositions and methods of use thereof
03/28/2013CA2849184A1 Liposome production using isopropanol
03/28/2013CA2849039A1 Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
03/28/2013CA2849037A1 Microbubble complexes and methods of use
03/28/2013CA2848943A1 Compositions and methods for treating conditions of compromised skin barrier function
03/28/2013CA2845388A1 Beta-lactam compounds for enhancing t cell-mediated immune responses
03/28/2013CA2843019A1 Anti-hla-dr antibodies suppress allogeneic and xenogeneic immune responses to organ transplants
03/27/2013EP2573112A1 Modulation of sirpa - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
03/27/2013EP2572780A1 Vesicles with encapsulated substance and production method therefor
03/27/2013EP2572734A2 Cytokine-based fusion proteins for treatment of immune disorders
03/27/2013EP2572733A1 Polymer-factor VIII moiety conjugates
03/27/2013EP2572732A1 Polymer-factor VIII moiety conjugates
03/27/2013EP2572731A1 Formulations based on solid dispersions
03/27/2013EP2572717A1 Pharmaceutical composition containing solifenacin
03/27/2013EP2572707A2 Microparticles with adsorbed polypeptide-containing molecules
03/27/2013EP2572706A1 Lipid membrane structure with nuclear transferability
03/27/2013EP2571900A1 Improved anti-serum albumin binding variants
03/27/2013EP2571896A2 Pegylated c-peptide
03/27/2013EP2571529A2 Functional, cross-linked nanostructures for tandem optical imaging and therapy
03/27/2013EP2571528A1 Novel self-reactive arms and prodrugs comprising same
03/27/2013EP2571527A1 Cationic lipids
03/27/2013EP2571526A1 Drug delivery devices for delivery of ocular therapeutic agents
03/27/2013EP2571525A1 Compositions and methods for treatment of autoimmune and other diseases
03/27/2013EP2571522A2 Cancer treatment
03/27/2013EP2571498A1 Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
03/27/2013EP2571493A1 Preparations of biologically active substances with enlarged surface area based on amphiphilic copolymers
03/27/2013EP2571490A2 Foam or particles for applications such as drug delivery
03/27/2013EP2571489A1 Injectable emulsion of sedative hypnotic agent
03/27/2013EP2571488A1 Pharmaceutical composition of ibuprofen for injection
03/27/2013EP2571362A1 Improved process for a folate-targeted agent
03/27/2013CN1852721B Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
03/27/2013CN103003422A New stabilizing agent for pharmaceutical proteins
03/27/2013CN103003303A Improved anti-serum albumin binding variants
03/27/2013CN103003301A 血清白蛋白结合分子 Serum albumin binding molecules
03/27/2013CN103002982A Vesicles with encapsulated substance and production method therefor
03/27/2013CN103002922A Peptide-carrying nanoparticles
03/27/2013CN103002921A Functional, cross-linked nanostructures for tandem optical imaging and therapy
03/27/2013CN103002920A Modified binding proteins inhibiting the VEGF-A receptor interaction
03/27/2013CN103002919A Tumor targeted delivery of immunomodulators by nanoplymers
03/27/2013CN103002918A Growth hormones with prolonged in-vivo efficacy
03/27/2013CN103002917A Antipsychotic injectable depot composition
03/27/2013CN103002908A Mucosal vaccine
03/27/2013CN103002891A Ratiometric combinatorial drug delivery
03/27/2013CN103002884A Intraocular pressure reduction with intracameral bimatoprost implants
03/27/2013CN103002879A Microvesicles derived from cell protoplast, and use thereof
03/27/2013CN103002875A Topical formulation for a jak inhibitor
03/27/2013CN103002810A Ultrasound coupling liquid and container
03/27/2013CN102994071A Organic and inorganic hybridization phosphorescence silicon dioxide magnetic nanoparticle and preparation and applications thereof
03/27/2013CN102993445A Gel production apparatus and gel production method
03/27/2013CN102993309A Human auxin fusion protein TAT-hGH as well as preparation method and application thereof
03/27/2013CN102993272A Targeted peptide of epidermal growth factor receptor (EGFR) and application thereof
03/27/2013CN102989038A Preparation method and application of collagen-based composite corneal substitute capable of delivering endothelial inhibitory hormone
03/27/2013CN102989016A Nanoparticle material with pH sensitivity and preparation method thereof
03/27/2013CN102989013A Preparation method for lymphatic vessel recognized carbon nanosphere
03/27/2013CN102989006A Preparation method of silicon-nanowire-based medicinal carrier
03/27/2013CN102989005A Methotrexate-loaded magnetosome drug carrier and preparation method thereof
03/27/2013CN102989004A Brain-targeting prodrug with vitamin C as carrier
03/27/2013CN102989003A Method for preparing oral naproxen-cyclodextrin inclusion
03/27/2013CN102989002A DOX-P micelle with anti-tumor drug resistance and preparation method thereof
03/27/2013CN102989001A Pegylated recombinant human growth hormone compounds
03/27/2013CN102989000A Process for preparing purified drug conjugates
03/27/2013CN102988999A Curcumin-polysaccharide conjugate as well as preparation method and application thereof
03/27/2013CN102988998A Poloxamer-adriamycin conjugate with anti-tumor effect and preparation method thereof
03/27/2013CN102988997A Drug-loaded nano particles, preparation method and application
03/27/2013CN102988996A Method for preparing stable albumin nanoparticle
03/27/2013CN102988995A Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT
03/27/2013CN102988994A Slow-release film-coated premixed agent and preparation method thereof
03/27/2013CN102988993A Screening and composition of main auxiliary materials of compound acetaminophen tablet, and preparation method of compound acetaminophen tablet
03/27/2013CN102988992A Composition for enhancing transdermal absorption of a drug and patch preparation
03/27/2013CN102988991A Composition for enhancing transdermal absorption of a drug and patch preparation
03/27/2013CN102988990A Composition for enhancing transdermal absorption of a drug and patch preparation
03/27/2013CN102988984A Aqueous drug preparation of anti-TNF (tumor necrosis factor)-alpha human monoclonal antibody for strengthening stability
03/27/2013CN102988754A Traditional Chinese medicine powder pad for treating lumbar disc herniation by cupping therapy
03/27/2013CN102988714A Spray drying prescription of extract powder of Chinese herbal compound, namely qi tonifying and tumor suppression decoction
03/27/2013CN102988542A Spina date seed and liquorice effervescent tablet
03/27/2013CN102988484A Phospholipid complex of natural Baikal skullcap root active ingredients as well as preparation method and preparation thereof
1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 1712